Skip to main content
. 2019 May 9;20(9):2302. doi: 10.3390/ijms20092302
MM Multiple myeloma
IMiDs immunomodulatory drugs
PIs proteasome inhibitors
IMWG International Multiple Myeloma Working Group
CRS cytokine release syndrome
FADD Fas-associated death domain
ROS Reactive oxygen species
HDACs histone deacetylases
HATs histone acetyltransferases
TMP tetramethylpyrazine
CK Compound K
SB Scutellaria baicalensis
TQ Thymoquinone
EGCG Epigallocatechin-3-gallate
DAPK2 death-associated protein kinase 2
VEGF vascular endothelial growth factor
PDGF platelet-derived growth factor
FGF fibroblast growth factor
EGF epidermal growth factor
TGFβ transforming growth factor beta
MMPs matrix metalloproteinase’s
TNF tumor necrosis factor
Ang-1 angiopoietins
uPAR urokinase receptor
BM bone marrow
BMM bone marrow microenvironment
PCDC4 programmed cell death 4
GR glucocorticoid receptors
ABM Agaricus blazei Murrill
PBMCs peripheral blood mononuclear cells